IP Library Granted Patent US 8,650,937
Granted Patent B2
US 8,650,937 · App. 12/563,046 · Granted Feb 18, 2014

Solute concentration measurement device and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,650,937
App. No.
12/563,046
Granted
Feb 18, 2014
Kind
B2
Abstract

A solute concentration measurement device is disclosed. The device may comprise a filter membrane, an exchange chamber, a sensing chamber, a separator, and a sensor. The device may be configured to be placed in fluid communication with a sample solution containing a solute and a solvent. The filter membrane may provide selective fluid communication between the solution and the exchange chamber. The separator may separate the exchange chamber from the sensing chamber and cause a change in a condition of the sensing chamber corresponding to a change of a condition of the exchange chamber. The sensor may sense the condition pertaining to the sensing chamber and calculate the concentration of the sample solution corresponding to this change.

Claims (29)

1. A device comprising, in combination:

a housing having disposed therein a filter membrane, an exchange chamber, and a sensing chamber containing a compressible fluid and a pressure sensor adapted to measure a pressure of the compressible fluid, wherein the filter membrane is exteriorly exposed on a perimeter of the housing and the exchange chamber is located internally of the filter membrane relative to the housing:

wherein the exchange chamber and sensing chamber are separated by a movable separator that moves in response to changes in the volume of the exchange chamber; and

wherein the device is adapted to measure the concentration of a solute in a sample solution utilizing, the measured pressure of the compressible fluid in the sensing chamber;

wherein the solute is glucose, and

wherein the filter membrane provides selective fluid communication between the sample solution and the exchange chamber, but is substantially impermeable to the solute.

2. The device of claim 1 , wherein sample solution is a body fluid of an animal.

3. The device of claim 1 , wherein movement of a fluid across the filter membrane causes a change in volume in the exchange chamber, the movement of the fluid occurring as the solute concentration in the exchange chamber equalizes with the concentration of the solute in the sample solution.

4. The device of claim 3 , wherein the change in volume in the exchange chamber causes movement of the separator, which thereby effects a change in pressure in the sensing chamber.

5. The device of claim 1 , wherein the pressure sensor detects the change in pressure in the sensing chamber.

6. The device of claim 1 , wherein the fiber membrane is an osmotic membrane.

7. The device of claim 1 , further comprising a microprocessor adapted to receive inputs from the pressure sensor, whereby the microprocessor substantially calculates the concentration of the solute in the sample solution.

8. The device of claim 1 , wherein the device is calibrated with a sample solution of known concentration.

9. The device of claim 1 , wherein the housing is implantable into a body of a patient.

10. The device of claim 1 , wherein the filter membrane is adapted to be in fluid communication with an ambient environment surrounding the housing.

11. A device comprising, in combination;

a housing having disposed therein a filter membrane, an exchange chamber, and a sensing chamber containing a compressible fluid and a pressure sensor adapted to measure a pressure of the compressible fluid, wherein the filter membrane is exteriorly exposed on a perimeter of the housing and the exchange chamber is located internally of the filter membrane relative to the housing;

wherein the exchange chamber and sensing chamber are separated by a movable separator that moves in response to changes in the volume of the exchange chamber; and

wherein the device is adapted to measure the concentration of a solute in a sample solution utilizing the measured pressure of the compressible fluid in the sensing chamber;

wherein the solute is glucose, and

wherein movement of a fluid across the filter membrane causes a change in volume in the exchange chamber, the movement of the fluid occurring as the solute concentration in the exchange chamber equalizes with the concentration of the solute in the sample solution.

12. The device of claim 11 , wherein sample solution is a body fluid of an animal.

13. The device of claim 11 , wherein the change in volume in the exchange chamber causes movement of the separator, which thereby effects a change in pressure in the sensing chamber.

14. The device o claim 11 , wherein the pressure sensor detects the change in pressure in the sensing chamber.

15. The device of claim 11 , wherein the filter membrane is an osmotic membrane.

16. The device of claim 11 , further comprising a microprocessor adapted to receive inputs from the pressure sensor, whereby the microprocessor substantially calculates the concentration of the solute in the sample solution.

17. The device of claim 11 , wherein the device is calibrated with a sample solution of known concentration.

18. The device of claim 11 , wherein the housing is implantable into a body of a patient.

19. The, device of claim 11 , wherein the filter membrane is adapted to be in fluid communication with an ambient environment surrounding the housing.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046763/0268 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046761/0843 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Apr 4, 2014
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 032608/0780 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Dec 26, 2012
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.
Reel/Frame 029529/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2009
From: BROWN, DAVID S.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 023615/0415 →